Catalogo Ricerca UNISI

Catalogo Ricerca UNISI: [93658] Home page macrotipologia

Sfoglia

1 Contributo su Rivista 56954
- 1.1 Articolo in rivista 52466
- 1.2 Recensione in rivista 1778
- 1.3 Scheda bibliografica 74
- 1.4 Nota a sentenza 741
- 1.5 Abstract in rivista 1865
- 1.6 Traduzione in rivista 30

2 Contributo in Volume 16983
- 2.1 Contributo in volume (Capitolo o Saggio) 14897
- 2.2 Prefazione/Postfazione 595
- 2.3 Breve introduzione 243
- 2.4 Voce (in dizionario o enciclopedia) 788
- 2.5 Traduzione in volume 71
- 2.6 Recensione in volume 38
- 2.7 Schede di catalogo 351

3 Libro 3161
- 3.1 Monografia o trattato scientifico 2847
- 3.2 Concordanza 4
- 3.3 Indice 11
- 3.4 Bibliografia 10
- 3.5 Edizione critica 90
- 3.6 Pubblicazione di fonti inedite 24
- 3.7 Commento scientifico 82
- 3.8 Traduzione di libro 93

4 Contributo in Atti di Convegno (Proceeding) 12153
- 4.1 Contributo in Atti di convegno 8397
- 4.2 Abstract in Atti di convegno 3340
- 4.3 Poster 416

5 Altro 1047
- 5.01 Composizione 2
- 5.02 Disegno 0
- 5.03 Design 0
- 5.04 Performance 0
- 5.05 Esposizione 3
- 5.06 Mostra 23
- 5.07 Manufatto 0
- 5.08 Prototipo d'arte e relativi progetti 0
- 5.09 Cartografia 157
- 5.10 Banca dati 54
- 5.11 Software 19
- 5.12 Articolo sul sito web 203
- 5.13 Altro 586

6 Brevetti 242
- 6.1 Brevetto 242

7 Curatele 1775
- 7.1 Curatela 1775

8 Tesi di dottorato 1346
- 8.1 Tesi Dottorato 1346

Prodotti recenti

Measurements of W+W− production cross-sections in pp collisions at s=13 TeV with the ATLAS detector

Measurements of W+W− → e±νμ∓ν production cross-sections are presented, providing a test of the predictions of perturbative quantum chromodynamics and the electroweak theory. The measurements are based on data from pp collisions at s = 13 TeV recorded by the ATLAS detector at the Large Hadron Collider in 2015–2018, corresponding to an integrated luminosity of 140 fb−1. The number of events due to top-quark pair production, the largest background, is reduced by rejecting events containing jets ...

ATLAS searches for additional scalars and exotic Higgs boson decays with the LHC Run 2 dataset

This report reviews the published results of searches for possible additional scalar particles and exotic decays of the Higgs boson performed by the ATLAS Collaboration using up to 140 fb−1 of 13 TeV proton–proton collision data collected during Run 2 of the Large Hadron Collider. Key results are examined, and observed excesses, while never statistically compelling, are noted. Constraints are placed on parameters of several models which extend the Standard Model, for example by adding one or ...

Search for light neutral particles decaying promptly into collimated pairs of electrons or muons in pp collisions at s = 13 TeV with the ATLAS detector

A search for a dark photon, a new light neutral particle, which decays promptly into collimated pairs of electrons or muons is presented. The search targets dark photons resulting from the exotic decay of the Standard Model Higgs boson, assuming its production via the dominant gluon-gluon fusion mode. The analysis is based on 140fb-1 of data collected with the ATLAS detector at the Large Hadron Collider from proton-proton collisions at a center-of-mass energy of 13 TeV. Events with colli...

Search for new particles in events with a hadronically decaying W or Z boson and large missing transverse momentum at s = 13 TeV using the ATLAS detector

A search is presented for new particles produced in proton-proton collisions at a centre-of-mass energy of 13 TeV that result in final states comprising a massive vector (W or Z) boson that decays hadronically and large missing transverse momentum. The data sample was collected with the ATLAS experiment at the Large Hadron Collider from 2015 to 2018 and corresponds to an integrated luminosity of 140 fb−1. No significant excess over the Standard Model expectation is observed. Model-independent...

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials

This real-world multicenter study aimed to evaluate the efficacy and tolerability of the isatuximab, pomalidomide, and dexamethasone (IsaPd) combination in relapsed/refractory multiple myeloma (RRMM). Our results confirm the safety and efficacy of IsaPd, in line with findings from the pivotal ICARIA-MM clinical trial.

Scopri

Accesso al fulltext

no fulltext44612
reserved33788
open13707
partially open1053
restricted246
internalNetwork154
embargoed86
mixed12